NASDAQ: URGNUrogen Pharma Ltd Stock Ownership - Who owns Urogen Pharma?
Insider buying vs selling
Have Urogen Pharma Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark Schoenberg | Chief Medical Officer | 2025-08-11 | 10,000 | $17.69 | $176.90kSell |
| Jason Drew Smith | General Counsel | 2025-07-28 | 7,522 | $19.14 | $143.97kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-07-28 | 5,149 | $19.14 | $98.55kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-06-09 | 5,162 | $7.37 | $38.04kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-01-31 | 1,896 | $11.14 | $21.12kSell |
| Jason Drew Smith | General Counsel | 2025-01-31 | 2,767 | $11.14 | $30.82kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-01-31 | 1,896 | $11.14 | $21.12kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-01-31 | 759 | $11.14 | $8.46kSell |
| Jason Drew Smith | General Counsel | 2025-01-31 | 1,258 | $11.14 | $14.01kSell |
| Jason Drew Smith | General Counsel | 2025-01-31 | 3,354 | $11.14 | $37.36kSell |
URGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when URGN insiders and whales buy or sell their stock.
URGN Shareholders
What type of owners hold Urogen Pharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ran Nussbaum | 16.64% | 7,674,072 | $149.87M | Insider |
| Rtw Investments LP | 9.86% | 4,543,895 | $88.74M | Institution |
| Toronto Dominion Bank | 6.92% | 3,190,510 | $62.31M | Institution |
| Morgan Stanley | 5.38% | 2,478,470 | $48.40M | Institution |
| Blackrock Inc | 5.22% | 2,405,241 | $46.97M | Institution |
| Jefferies Financial Group Inc | 4.77% | 2,199,652 | $42.96M | Institution |
| Soleus Capital Management LP | 4.74% | 2,185,000 | $42.67M | Institution |
| Silverarc Capital Management LLC | 4.39% | 2,022,482 | $39.50M | Institution |
| Acorn Capital Advisors LLC | 2.73% | 1,259,749 | $24.60M | Institution |
| Proquest Investments IV LP | 2.69% | 1,242,031 | $24.26M | Insider |
URGN vs Biotech Stocks
Urogen Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.